Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, China.
Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
Int Urol Nephrol. 2023 Sep;55(9):2285-2293. doi: 10.1007/s11255-023-03525-0. Epub 2023 Mar 3.
The harmful effect of diabetes mellitus (DM) on mortality in patients with heart failure with reduced ejection fraction (HFrEF) remains controversial. Furthermore, it seems that no consistent conclusion on whether chronic kidney disease (CKD) modifies the relationship of DM and poor prognosis in patients with HFrEF.
We analyzed the individuals with HFrEF from the Cardiorenal ImprovemeNt (CIN) cohort between January 2007 and December 2018. The primary endpoint was all-cause mortality. The patients were divided into four groups (control vs. DM alone vs. CKD alone vs. DM and CKD). Multivariate Cox proportional hazards analysis was conducted to examine the association among DM, CKD and all-cause mortality.
There were 3,273 patients included in this study (mean age: 62.7 ± 10.9 years, 20.4% were female). During a median follow-up of 5.0 years (interquartile range: 3.0-7.6 years), 740 (22.6%) patients died. Patients with DM have a higher risk of all-cause mortality (HR [95% confidence interval (CI)]:1.28[1.07-1.53]) than those without DM. In patients with CKD, DM had a 61% (HR [95% CI]:1.61[1.26-2.06]) increased adjusted risk of death relative to non-DM, while in patients with non-CKD, there was no significantly difference in risk of all-cause mortality (HR [95% CI]:1.01[0.77-1.32]) between DM and non-DM (p for interaction = 0.013).
Diabetes is a potent risk factor for mortality in patients with HFrEF. Furthermore, DM had a substantially different effect on all-cause mortality depending on CKD. The association between DM and all-cause mortality was only observed in patients with CKD.
糖尿病(DM)对射血分数降低的心力衰竭(HFrEF)患者死亡率的有害影响仍存在争议。此外,似乎没有关于慢性肾脏病(CKD)是否改变 DM 与 HFrEF 患者不良预后之间关系的一致结论。
我们分析了 2007 年 1 月至 2018 年 12 月期间 Cardiorenal ImprovemeNt(CIN)队列中的 HFrEF 个体。主要终点是全因死亡率。患者分为四组(对照组 vs. 单独 DM 组 vs. 单独 CKD 组 vs. DM 和 CKD 组)。多变量 Cox 比例风险分析用于检查 DM、CKD 和全因死亡率之间的关系。
这项研究共纳入 3273 名患者(平均年龄:62.7±10.9 岁,20.4%为女性)。中位随访时间为 5.0 年(四分位距:3.0-7.6 年),740 名(22.6%)患者死亡。与无 DM 患者相比,DM 患者全因死亡率风险更高(HR[95%置信区间(CI)]:1.28[1.07-1.53])。在 CKD 患者中,DM 患者死亡的调整风险增加了 61%(HR[95%CI]:1.61[1.26-2.06]),而在非 CKD 患者中,DM 和非 DM 患者的全因死亡率风险无显著差异(HR[95%CI]:1.01[0.77-1.32])(p 交互 = 0.013)。
糖尿病是 HFrEF 患者死亡的一个强有力的危险因素。此外,DM 对全因死亡率的影响因 CKD 而有很大差异。DM 与全因死亡率之间的关联仅在 CKD 患者中观察到。